Boxer Capital, LLC - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 127 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Boxer Capital, LLC ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$30,039,385
+103021.8%
1,466,0510.0%1.60%
+18.4%
Q2 2023$29,130
+16.0%
1,466,0510.0%1.35%
+9.5%
Q1 2023$25,113
-99.9%
1,466,0510.0%1.23%
-18.4%
Q4 2022$28,690,618
+22.6%
1,466,0510.0%1.51%
+14.9%
Q3 2022$23,398,000
+16.0%
1,466,0510.0%1.32%
+3.0%
Q2 2022$20,173,000
-13.2%
1,466,0510.0%1.28%
+6.9%
Q1 2022$23,252,000
-27.3%
1,466,0510.0%1.20%
-3.9%
Q4 2021$32,004,000
-27.0%
1,466,0510.0%1.24%
-18.8%
Q3 2021$43,820,000
-32.5%
1,466,0510.0%1.53%
-33.2%
Q2 2021$64,931,000
-0.2%
1,466,0510.0%2.29%
+3.9%
Q1 2021$65,049,000
-19.1%
1,466,0510.0%2.21%
-14.6%
Q4 2020$80,398,000
+139.9%
1,466,0510.0%2.58%
+123.1%
Q3 2020$33,514,000
+9.2%
1,466,0510.0%1.16%
-14.2%
Q2 2020$30,684,000
+50.0%
1,466,0510.0%1.35%
-3.2%
Q1 2020$20,451,000
-38.7%
1,466,0510.0%1.39%
-26.1%
Q4 2019$33,367,000
+95.4%
1,466,0510.0%1.89%
+52.4%
Q3 2019$17,079,000
-22.3%
1,466,0510.0%1.24%
-34.5%
Q2 2019$21,991,000
-14.5%
1,466,0510.0%1.89%
-36.4%
Q1 2019$25,715,000
-11.7%
1,466,051
-25.4%
2.97%
-17.4%
Q4 2018$29,137,000
-39.8%
1,966,0510.0%3.60%
-33.0%
Q3 2018$48,404,000
+25.4%
1,966,0510.0%5.37%
+22.9%
Q2 2018$38,594,000
+4.7%
1,966,0510.0%4.37%
+11.1%
Q1 2018$36,863,0001,966,0513.94%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 16,812,491$234,534,00010.10%
TANG CAPITAL MANAGEMENT LLC 2,965,485$41,369,0005.81%
Ghost Tree Capital, LLC 650,000$9,068,0002.40%
Boxer Capital, LLC 1,466,051$20,451,0001.39%
Vivo Capital, LLC 860,648$12,006,0001.09%
Samsara BioCapital, LLC 128,197$1,788,0001.03%
Cormorant Asset Management, LP 1,568,550$21,881,0001.02%
Perceptive Advisors 2,189,010$30,537,0000.80%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,677,367$23,399,0000.74%
Eventide Asset Management 1,415,000$19,739,0000.64%
View complete list of ROCKET PHARMACEUTICALS INC shareholders